Atlas Special Opportunities

Atlas Special Opportunities is an investment fund that offers innovative solutions to people in need of finance. They are credit-oriented, but in addition to lending, they are willing to purchase an asset or equity or function as a merchant partner in arranging a transaction between two parties. Their mission is to help individuals, organizations, and asset owners achieve what they want.

Mustapha Raddi

Co-Founder

Past deals in Belgium

Oxurion

Post in 2024
Oxurion is a clinical-stage biopharmaceutical company based in Belgium, focused on developing advanced ophthalmic therapies aimed at preserving vision in patients suffering from retinal vascular disorders. Its primary target conditions include diabetic macular edema, wet age-related macular degeneration, and retinal vein occlusion, which are significant causes of vision loss worldwide. The company is dedicated to creating innovative treatments that enhance the standard of care for these debilitating eye diseases.

Oxurion

Post in 2024
Oxurion is a clinical-stage biopharmaceutical company based in Belgium, focused on developing advanced ophthalmic therapies aimed at preserving vision in patients suffering from retinal vascular disorders. Its primary target conditions include diabetic macular edema, wet age-related macular degeneration, and retinal vein occlusion, which are significant causes of vision loss worldwide. The company is dedicated to creating innovative treatments that enhance the standard of care for these debilitating eye diseases.

Oxurion

Post in 2023
Oxurion is a clinical-stage biopharmaceutical company based in Belgium, focused on developing advanced ophthalmic therapies aimed at preserving vision in patients suffering from retinal vascular disorders. Its primary target conditions include diabetic macular edema, wet age-related macular degeneration, and retinal vein occlusion, which are significant causes of vision loss worldwide. The company is dedicated to creating innovative treatments that enhance the standard of care for these debilitating eye diseases.

Oxurion

Post in 2023
Oxurion is a clinical-stage biopharmaceutical company based in Belgium, focused on developing advanced ophthalmic therapies aimed at preserving vision in patients suffering from retinal vascular disorders. Its primary target conditions include diabetic macular edema, wet age-related macular degeneration, and retinal vein occlusion, which are significant causes of vision loss worldwide. The company is dedicated to creating innovative treatments that enhance the standard of care for these debilitating eye diseases.

Drone Volt

Post in 2022
Drone Volt SA is a manufacturer and distributor of professional civilian drones, headquartered in Villepinte, France. Established in 2011, the company operates in multiple countries, including Belgium, the Netherlands, Canada, Denmark, the United States, Switzerland, and Indonesia. Drone Volt provides a range of commercial drones designed for various applications such as inspection, surveillance, thermography, and search and rescue missions, targeting sectors like energy, construction, security, and agriculture. In addition to its own drone products, the company also distributes DJI drones and accessories for civil and commercial use. Drone Volt offers a comprehensive suite of services, including engineering consulting, aerial data acquisition, professional drone training, maintenance, and legal support. The company serves a diverse clientele, including government agencies and industrial groups, while also exporting its products globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.